Expression of the Pro-Domain–Deleted Active Form of Caspase-6 in Escherichia coli
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Caspases are a family of cysteine proteases that play an important role in the apoptotic pathway. Caspase-6 is an apoptosis effector that cleaves a variety of cellular substrates. The active form of the enzyme is required for use in research. However, it has been difficult to obtain sufficient quantities of active caspase-6 from Escherichia coli. In the present study, we constructed a caspase-6 with a 23-amino-acid deletion in the pro-domain. This engineered enzyme was expressed as a soluble protein in E. coli and was purified using affinity resin. In vitro enzyme assay and cleavage analysis revealed that the engineered active caspase-6 protein had characteristics similar to those of wild-type caspase-6. This novel method can be a valuable tool for obtaining active caspase-6 that can be used for screening caspase-6–specific substrates, which in turn can be used to elucidate the function of caspase-6 in apoptosis.
Abstract
Caspases are a family of cysteine proteases that play an important role in the apoptotic pathway. Caspase-6 is an apoptosis effector that cleaves a variety of cellular substrates. The active form of the enzyme is required for use in research. However, it has been difficult to obtain sufficient quantities of active caspase-6 from Escherichia coli. In the present study, we constructed a caspase-6 with a 23-amino-acid deletion in the pro-domain. This engineered enzyme was expressed as a soluble protein in E. coli and was purified using affinity resin. In vitro enzyme assay and cleavage analysis revealed that the engineered active caspase-6 protein had characteristics similar to those of wild-type caspase-6. This novel method can be a valuable tool for obtaining active caspase-6 that can be used for screening caspase-6–specific substrates, which in turn can be used to elucidate the function of caspase-6 in apoptosis.
참고문헌 (15)
- Brown JM, "The role of apoptosis in cancer development and treatment response", Nat. Rev. Cancer, 5, pp.231~237 (2005)
- Ekici OD, "Design, synthesis, and evaluation of azapeptide Michael acceptors as selective and potent inhibitors of caspases-2, -3, -6, -7, -8, -9, and -10", J. Med. Chem, 49, pp.5728~5749 (2006)
- 장미, "Mining of Caspase-7 Substrates Using a Degradomic Approach", Molecules and Cells, 26(2), pp.152~157 (2008), 한국분자세포생물학회
- Lamkanfi M, "Alice in caspase land. A phylogenetic analysis of caspases from worm to man", Cell Death Differ, 9, pp.358~361 (2002)
- Lazebnik YA, "Cleavage of poly(ADP-ribose)polymerase by a proteinase with properties like ICE", Nature, 371, pp.346~347 (1994)
- Lee AY, "Identification of caspase-3 degradome by two-dimensional gel electrophoresis and matrix-assisted laser desorption", ionization-time of flight analysis, 2004, pp.4, 3429~3436
- Letai AG, "Diagnosing and exploiting cancer’s addiction to blocks in apoptosis", Nat. Rev. Cancer, 8, pp.121~132 (2008)
- Linton SD., "Caspase inhibitors: a pharmaceutical industry perspective", Curr. Top. Med. Chem, 5, pp.1697~1716 (2005)
- Loetscher H, "Is caspase-3 inhibition a valid therapeutic strategy in cerebral ischemia?", Drug Discov. Today, 6, pp.671~680 (2001)
- Mattson MP., "Apoptosis in neurodegenerative disorders", Nat. Rev. Mol. Cell Biol, 1, pp.120~129 (2000)
- Miura M, "Induction of apoptosis in fibroblasts by IL-1β-converting enzyme, a mammalian homolog of the C. elegans cell death gene ced-3", Cell, 75, pp.653~660 (1993)
- Nicholson DW, "Identification and inhibition of the ICE", CED-3 protease necessary for mammalian apoptosis, 1995, pp.376, 37~43
- Schimmer AD, "Targeting XIAP for the treatment of malignancy", Cell Death Differ, 13, pp.179~188 (2006)
- Taylor RC, "Apoptosis: controlled demolition at the cellular level", Nat. Rev. Mol. Cell Biol, 9, pp.231~241 (2008)
- Voss OH, "Binding of caspase-3 prodomain to heat shock protein 27 regulates monocyte apoptosis by inhibiting caspase-3 proteolytic activation", J. Biol. Chem, 282, pp.25088~25099 (2007)